insomnia, slaapstoornissen Insomnia sleeplessness
Conditions
Interventions
Intervention: i-Sleep Autism is an adapted version of i-Sleep, a guided 
e-health intervention based on CBTi principles, aimed at improving sleep 
problems (insomnia) in autistic adults. It consists of 5 modules, which are to 
be completed in about 5 weeks, and a sleep diary. The intervention will be 
entirely held online, and participants will receive weekly feedback from a 
coach.
Sponsors
Vrije Universiteit
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: In order to be eligible to participate in this study, the following inclusion criteria apply: (1) A participant must have a formal clinical diagnosis of Autism Spectrum Disorder (ASD) as established by an authorized professional (e.g., psychiatrist/psychologist). This information is provided by the participant. (2) A participant must be at least 18 years of age. (3) A participant must have self-reported insomnia, with a cut-off score of 10 or higher on the Insomnia Severity Index. (4) A participant must possess a desktop, laptop, tablet or mobile phone with internet connectivity. The Minddistrict platform (on which the intervention will be provided) does not have minimal hardware specifications. Minddistrict and the Minddistrict app work best on modern devices that are not older than 5 years, with a preference for devices that are not older than 3 years. (5) A participant must be able to read and write in the Dutch language.
Exclusion criteria
Exclusion criteria: The following exclusion criteria apply to potential participants: (1) Not being able to comply to the intervention due to night shifts, meaning work between 2AM and 6AM at least once a week. (2) Current or planned pregnancy or breast feeding, since sleep problems often occur in pregnancy and parents of a newborn. Other comorbid psychological disorders and somatic diseases are allowed, since rates of psychiatric comorbidity are very high (81%) in this population (Vohra et al., 2018). The use of (sleep) medication is also allowed and tracked by asking: *Have you used sleep medication in the past 4 weeks?* (Yes/no). If yes, we will ask which medications and how frequently these medications were taken. Cannabis will also be included in the list of medications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main study parameters/endpoints: The primary outcome will be insomnia severity. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes will be mental health, quality of life, depression, anxiety, and daily functioning. Outcomes will be measured at baseline, mid-intervention (3 weeks), at post-intervention (6 weeks after baseline), and at 6 months follow up. We will also explore moderators (expectations, preference, motivation, baseline symptom severity, insomnia duration) of the intervention effect. | — |
Countries
Netherlands
Outcome results
None listed